K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9192830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of low‐fraction K‐ras mutations in primary lung tumors using a sensitive method

  1997cited by this paper
• Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.

  1997cited by this paper
• Polyclonal Origin of Colonic Adenomas in an XO/XY Patient with FAP

  1996cited by this paper
• Mutant K‐ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis

  1995cited by this paper
• Frequent and characteristic K‐ras activation in aberrant crypt foci of colon. Is there preference among K‐ras mutants for malignant progression?

  1995cited by this paper
• Geographic variation of p53 mutational profile in nonmalignant human liver.

  1994cited by this paper
• Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.

  1994cited by this paper
• K-ras mutations in putative preneoplastic lesions in human colon.

  1993cited by this paper
• Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis.

  1993cited by this paper
• Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.

  1993cited by this paper
• APC mutations occur early during colorectal tumorigenesis

  1992cited by this paper
• Mutational spectrometry: a general approach for hot-spot point mutations in selectable genes.

  1992cited by this paper
• Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver

  1991cited by this paper
• Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.

  1991cited by this paper
• Aberrant crypts: putative preneoplastic foci in human colonic mucosa.

  1991cited by this paper
• 3 – Kinetics of Normal, Preneoplastic, and Neoplastic Colonic Epithelium

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Histogenesis of Colorectal Carcinoma

  1989cited by this paper
• Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.

  1989cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

  1988cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Analysis of RAS oncogene mutations in human lymphoid malignancies.

  1988cited by this paper
• Prevalence of ras gene mutations in human colorectal cancers

  1987cited by this paper
• Clonal analysis of human colorectal tumors.

  1987cited by this paper
• Direct examination of the clonality of carcinogen-induced colonic epithelial dysplasia in chimeric mice.

  1986cited by this paper
• DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory.

  1983cited by this paper

• The Five-year KRAS, NRAS and BRAF Analysis Results and Treatment Patterns in Daily Clinical Practice in Slovenia in 1st Line Treatment of Metastatic Colorectal (mCRC) Patients with RAS Wild-type Tumour (wtRAS) – A Real- Life Data Report 2013–2018

  2023cites this paper
• Impact of risk factors on early cancer evolution.

  2023cites this paper
• Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity.

  2022cites this paper
• Toward Early Diagnosis of Colorectal Cancer: Focus on Optical Nano Biosensors.

  2022cites this paper
• Pulmonary Inflammation and KRAS Mutation in Lung Cancer.

  2021cites this paper
• Colorectal Adenomas—Genetics and Searching for New Molecular Screening Biomarkers

  2020cites this paper
• Accumulation of Somatic Mutations in Normal Human Colonic Epithelium

  2020influential citation
• GENOMIC AND TRANSCRIPTOMIC LANDSCAPE OF COLORECTAL PREMALIGNANCY

  2018cites this paper
• Aging and the rise of somatic cancer-associated mutations in normal tissues

  2018cites this paper
• Sequence‐dependent cleavage of mismatched DNA by Ban I restriction endonuclease

  2017cites this paper
• Cellular protection mechanisms that minimise accumulation of mutations in intestinal tissue.

  2017cites this paper
• New insights into the earliest stages of colorectal tumorigenesis

  2017cites this paper
• Clonal evolution of colorectal cancer in IBD

  2017cites this paper
• K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

  2017cites this paper
• Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis

  2017cites this paper
• Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer

  2017cites this paper
• Tumor‐associated DNA mutation detection in individuals undergoing colonoscopy

  2017cites this paper
• Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates

  2016cites this paper
• Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions

  2016cites this paper
• HistoMosaic Detecting KRAS G12V Mutation Across Colorectal Cancer Tissue Slices through in Situ PCR.

  2016cites this paper
• CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.

  2015cites this paper
• Adenoma and carcinoma components in colonic tumors show discordance for KRAS mutation.

  2014cites this paper
• The Presence of Telomere Fusion in Sporadic Colon Cancer Independently of Disease Stage, TP53/KRAS Mutation Status, Mean Telomere Length, and Telomerase Activity

  2014cites this paper
• Stem cell dynamics in homeostasis and cancer of the intestine

  2014cites this paper
• Mutation detection in normal mucosa and early lesions of colorectal cancer

  2014cites this paper
• Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion

  2013cites this paper
• Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer

  2013cites this paper
• Pre‐tumour clones, periodic selection and clonal interference in the origin and progression of gastrointestinal cancer: potential for biomarker development

  2013cites this paper
• Biology and diagnosis of aberrant crypt foci

  2012cites this paper
• Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

  2012cites this paper
• Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia

  2011cites this paper
• Management Strategies for Patients with KRAS Mutations

  2010cites this paper
• Novel Agents in the Treatment of Metastatic Colorectal Cancer

  2010cites this paper
• High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice.

  2010cites this paper
• ACB-PCR quantification of K-RAS codon 12 GAT and GTT mutant fraction in colon tumor and non-tumor tissue.

  2010cites this paper
• Characteristics of Colorectal Location of Synchronous Multiple Tumors during Colonoscopy

  2010cites this paper
• ACB-PCR Quantification of K-RAS Codon 12 GAT and GTT Mutant Fraction in Colon Tumor and Non-Tumor Tissue

  2010cites this paper
• A novel mutant allele specific amplification and electrochemiluminescence method for the detection of point mutation in clinical samples.

  2009cites this paper
• The importance of KRAS status in managing metastatic colorectal cancer

  2009cites this paper
• Evaluation of ras Mutations in Filipino Colorectal Patients

  2009cites this paper
• High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice.

  2008cites this paper
• The Genomics of Colorectal Cancer: State of the Art

  2008cites this paper
• Many different tumor types have polyclonal tumor origin: evidence and implications.

  2008cites this paper
• Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer

  2006influential citation
• K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer.

  2006cites this paper
• Senescence and serration: a new twist to an old tale

  2006cites this paper
• Associations of Ki-ras Proto-oncogene Mutation and p53 Gene Overexpression in Sporadic Colorectal Adenomas with Demographic and Clinicopathologic Characteristics

  2006influential citation
• Einfluss von Karotten- und Tomatensaft-Konsum auf Coloncarcinogenese-relevante Faecesmarker beim Menschen

  2005cites this paper
• Increase in the frequency of K‐ras codon 12 point mutation in colorectal carcinoma in elderly males in Japan: The 1990s compared with the 1960s

  2005cites this paper
• Stool screening for colorectal cancer: molecular approaches.

  2005cites this paper
• Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions.

  2004cites this paper
• The evolution to stool DNA testing for colorectal cancer

  2004cites this paper
• Simultaneous Mutations in K-ras and TP53 Are Indicative of Poor Prognosis in Sporadic Colorectal Cancer

  2004cites this paper
• Clinical usefulness of K-RAS mutation detection in colorectal cancer and in surgical margins of the colon.

  2004cites this paper
• Molecular stool screening for colorectal cancer

  2004cites this paper
• Detection of low abundant mutations in DNA using single-molecule FRET and ligase detection reactions

  2003cites this paper
• DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility.

  2003cites this paper
• Distribution of genetic variants in preneoplastic areas of colorectal tumours.

  2003cites this paper
• Approaching real-time molecular diagnostics: single-pair fluorescence resonance energy transfer (spFRET) detection for the analysis of low abundant point mutations in K-ras oncogenes.

  2003cites this paper
• A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up

  2003cites this paper
• Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer

  2003cites this paper
• DNA Methylation, a Biomarker for Colorectal Cancer

  2003cites this paper
• Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations

  2002cites this paper
• The colorectal adenoma–carcinoma sequence

  2002cites this paper
• Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers

  2002cites this paper
• Stool screening for colorectal cancer: evolution from occult blood to molecular markers.

  2002cites this paper
• up strong prognostic indicator in postoperative follow the serum of patients with colorectal neoplasia : inKRAS 2 A prospective study of circulating mutant

  2002cites this paper
• Molecular screening for colon cancer in inflammatory bowel disease

  2002cites this paper
• Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.

  2002cites this paper
• K-ras mutation detection by hybridization to a polypyrrole DNA chip.

  2001cites this paper
• APC and K-ras gene mutation in aberrant crypt foci of human colon.

  2001cites this paper
• Topographic analysis of K-ras mutations in histologically normal lung tissues and tumours of lung cancer patients

  2001cites this paper
• Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment.

  2001cites this paper
• Detection of alcoholic liver disease.

  2001cites this paper
• Detecting Rare Mutations Associated with Cancer Risk

  2001cites this paper
• Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics.

  2001cites this paper
• Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA.

  2000cites this paper
• ["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].

  2000cites this paper
• Field defects in progression to adenocarcinoma of the colon and esophagus

  2000influential citation
• Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

  2000cites this paper
• Characterization of the E‐cadherin–catenin complexes in pancreatic carcinoma cell lines

  1999cites this paper
• Early expression of cyclo‐oxygenase‐2 during sporadic colorectal carcinogenesis

  1999cites this paper
• Sampling technique influences the detection of K-ras mutations in normal appearing mucosa of colorectal cancer patients.

  1999cites this paper
• c-Ki-ras mutations in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence

  1999cites this paper
• 11 – DIET AND CANCER

  1999cites this paper
• Stereospecific differences in repair by human cell extracts of synthesized oligonucleotides containing trans-opened 7,8,9, 10-tetrahydrobenzo[a]pyrene 7,8-diol 9,10-epoxide N2-dG adduct stereoisomers located within the human K-ras codon 12 sequence.

  1999cites this paper
• Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.

  1999cites this paper
• Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors

  1999cites this paper
• Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.

  1999cites this paper
• K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa.

  1998cites this paper
• Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression.

  1998cites this paper
• Microdissection-Based p53 Genotyping: Concepts for Molecular Testing.

  1998cites this paper
• Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.

  1998cites this paper